May 23, 2014 — AliveCor Inc. announced studies presented at the Heart Rhythm Society's (HRS) 35th annual scientific sessions expand the growing body of clinical information evaluating the use of the AliveCor heart monitor.
May 23, 2014 — Medtronic announced the results from the first prospective randomized clinical trial to show that Medtronic implantable cardioverter-defibrillators (ICDs) can safely extend detection times before triggering therapy in secondary prevention patients. The results of the PainFree SST sub-study were unveiled as a late-breaking presentation at the Heart Rhythm Society's (HRS) 35th annual scientific sessions.
Improved understanding of the molecular mechanism of atherogenesis will help identify disease-related pathways and biomarkers that may also help to predict the future risk in asymptomatic individuals. Novel technologies, such as high-throughput sequencing have enabled scientists to gain better insights into diseases and disease progression.
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
Extending the "Evolution of Visual Healthcare" to mobile devices, Agfa HealthCare launched its new Web-enabled mobile image management technology that brings the power of ICIS to iPhones, iPads, Web and Android mobile digital devices.
A study presented at Heart Rhythm 2014, the Heart Rhythm Society’s 35th Annual Scientific Sessions, reports significant gender and health insurance disparities in implantable cardioverter defibrillator (ICD) procedures.
Hospira Inc. issued a nationwide recall to the user level for one lot of Dobutamine Injection, USP, 250 mg, 20 mL, single-dose fliptop vial, (NDC 0409-2344-02), Lot 27-352-DK. (NDC and lot number can be found on the right-hand side of the primary label).
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
May 21, 2014 — Siemens Healthcare announced that the U.S. Food and Drug Administration (FDA) cleared the Somatom Force computed tomography (CT) system — the next generation in dual source CT.
Patients with hypertension after renal artery stenting who do not respond to drug treatment may have another option.
May 21, 2014 — iRhythm Technologies Inc. announced that data from four studies presented at Heart Rhythm 2014, the Heart Rhythm Society's 35th Annual Scientific Sessions, support the use of the company's Zio Service to identify atrial fibrillation (AF) and other cardiac arrhythmias.
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
The FDA has recognized 3-D printing technology now exists to print medical devices and is gathering information regarding technical assessments that should be considered when it will inevitably begin reviewing these types of future FDA submissions.
Sony Electronics’ Medical Systems Division showcased a full line of medical grade monitors for radiology applications, including the LMD-DM50, LMD-DM30C and LMD-DM30 models, at the 2014 Society for Imaging Informatics in Medicine (SIIM) meeting, in Long Beach, Calif.
St. Jude Medical Inc. announced that the first patient implants occurred in the Portico Re-sheathable Transcatheter Aortic Valve System U.S. IDE Trial (PORTICO trial).
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
May 20, 2014 — Siemens Healthcare announced the U.S. Food and Drug Administration (FDA) has cleared the 16- and 32-slice iterations of its Somatom Perspective computed tomography (CT) system.
May 20, 2014 — GE Healthcare and Tesla Engineering Ltd. are collaborating to produce 7T human whole-body magnetic resonance imaging (MRI) scanners. The companies made the announcement at the joint meeting of the International Society for Magnetic Resonance in Medicine (ISMRM) and the European Society for Magnetic Resonance in Medicine and Biology (ESMRMB) in Milan.
Transcatheter Technologies GmbH, an emerging medical device company that is developing a third-generation transcatheter aortic valve implantation (TAVI) system — Trinity) — announced that its founder and CEO, Wolfgang Goetz, M.D., Ph.D., will be meeting with potential investors, including potential corporate partners, at the EuroPCR annual scientific meeting in Paris, May 20-23.